Smoking and diabetes interplay: A comprehensive review and joint statement.

Autor: Durlach V; Champagne-Ardenne University, UMR CNRS 7369 MEDyC & Cardio-Thoracic Department, Reims University Hospital, Reims, France. Electronic address: vincent.durlach@univ-reims.fr., Vergès B; Department of Endocrinology, Diabetology and Metabolic Diseases, CHU Dijon, Dijon, France; INSERM LNC-UMR1231, University of Burgundy, Dijon, France., Al-Salameh A; Department of Endocrinology, Diabetes Mellitus and Nutrition, Amiens University Hospital, Amiens, France; PériTox = UMR-I 01, University of Picardy Jules Verne, Amiens, France., Bahougne T; Department of Endocrinology and Diabetology, Strasbourg University Hospital, Strasbourg, France; Institute of Cellular and Integrative Neuroscience, CNRS UPR-3212, Strasbourg, France., Benzerouk F; Cognition Health and Society Laboratory (EA 6291), University of Reims Champagne-Ardenne, Reims, France; Department of Psychiatry, Reims University Hospital, Reims, France., Berlin I; Department of Pharmacology, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France., Clair C; Department of Training, Research and Innovation, Center for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland., Mansourati J; EA 4324 ORPHY, University of Western Brittany, Brest, France; Department of Cardiology, University Hospital of Brest, Brest, France., Rouland A; Department of Endocrinology, Diabetology and Metabolic Diseases, CHU Dijon, Dijon, France., Thomas D; Institute of Cardiology, Hôpital Pitié-Salpêtrière, Sorbonne University, Paris, France., Thuillier P; Department of Endocrinology, Diabetology and Metabolic Diseases, University Hospital of Brest, Brest, France., Tramunt B; Institute of Metabolic and Cardiovascular Diseases, UMR1297 INSERM/UPS, Toulouse University, Toulouse, Franc; Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France., Le Faou AL; Outpatient Addiction Center, Georges Pompidou European Hospital, AP-HP, Sorbonne Paris Cité, Paris, France.
Jazyk: angličtina
Zdroj: Diabetes & metabolism [Diabetes Metab] 2022 Nov; Vol. 48 (6), pp. 101370. Date of Electronic Publication: 2022 Jun 29.
DOI: 10.1016/j.diabet.2022.101370
Abstrakt: Evidence shows that smoking increases the risk of pre-diabetes and diabetes in the general population. Among persons with diabetes, smoking has been found to increase the risk of all-cause mortality and aggravate chronic diabetic complications and glycemic control. The current paper, which is a joint position statement by the French-Speaking Society on Tobacco (Société Francophone de Tabacologie) and the French-Speaking Society of Diabetes (Société Francophone du Diabète), summarizes the data available on the association between smoking and diabetes and on the impact of smoking and smoking cessation among individuals with type 1, type 2, and gestational diabetes mellitus. It also provides evidence-based information about the pharmacological and behavioral strategies for smoking cessation in these patients.
Competing Interests: Declaration of Competing Interest Vincent Durlach has acted as an advisory board member, speaker, and/or consultant for Amgen, Sanofi, Lilly, Servier, and Bioprojet. Bruno Vergès reports grants, honoraria and institutional funding from Amgen, AstraZeneca, Bayer Pharma, Boehringer-Ingelheim, LifeScan, Lilly, MSD, Novo Nordisk, and Recordati. Abdallah Al-Salameh reports personal fees from Novo Nordisk, AstraZeneca, and Lilly. Daniel Thomas has received honoraria from Pfizer for punctual consulting, lectures and presentations, and support for attending meetings/travel. Philippe Thuillier reports personal fees from Novo Nordisk and Sanofi. Blandine Tramunt reports personal fees from Novo Nordisk and Lilly. Anne-Laurence Le Faou has received personal fees from Pfizer and Johnson and Johnson. The other authors declare that they have no conflicting interests.
(Copyright © 2022 Elsevier Masson SAS. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: